Pathstone Holdings
BMRN icon

Pathstone Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Pathstone Holdings’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$510K Sell
9,020
-456
-5% -$26.6K ﹤0.01% 1745
2025
Q4 		$563K Buy
9,476
+1,281
+16% +$69.7K ﹤0.01% 1701
2025
Q3 		$444K Sell
8,195
-276
-3% -$15.8K ﹤0.01% 1823
2025
Q2 		$466K Sell
8,471
-1,478
-15% -$87K ﹤0.01% 1751
2025
Q1 		$703K Buy
9,949
+77
+0.8% +$5.18K ﹤0.01% 1550
2024
Q4 		$649K Sell
9,872
-39
-0.4% -$2.61K ﹤0.01% 1614
2024
Q3 		$697K Hold
9,911
– – ﹤0.01% 1555
2024
Q2 		$816K Buy
9,911
+742
+8% +$61.8K ﹤0.01% 1434
2024
Q1 		$801K Buy
9,169
+1,855
+25% +$166K ﹤0.01% 1424
2023
Q4 		$705K Buy
+7,314
New +$647K ﹤0.01% 1294

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return